drugset / Trial / NCT01433757
Ampicillin for DYT-1 Dystonia Motor Symptoms
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate if the antibiotic Ampicillin is safe and tolerated in patients that have generalized dystonia caused by the DYT-1 gene mutation, as compared to patients treated with a placebo. A placebo is a pill that looks and tastes the same as the real drug, but without the active ingredient. The second objective of this study is to determine if dystonia symptoms improve while on the study drug.
Timeline
- Start
- 2011-09
- Primary completion
- 2017-06
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ampicillin | Unknown | 1 mg | Oral |
| Comparator | Ampicillin | Unknown | 2 mg | Oral |